top of page
News
Press Releases
Inflection Biosciences & RCSI enter research collaboration to target Therapy Resistant BC treatment.
Dublin, Ireland, November 23, 2017 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, and...
Nov 23, 2017
Inflection Biosciences to Present at Investor Conferences in November 2017
Dublin, Ireland, November 2, 2017 Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...
Nov 2, 2017
Inflection Biosciences Announces Pre-clinical Data to be Presented at 2nd EACR-AACR-SIC Special Conf
Dublin, Ireland, June 23, 2017 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...
Jun 23, 2017
Inflection Biosciences Announces Pre-clinical Data on IBL-202 to be Presented at IWCLL 2017
Dublin, Ireland, May 15th, 2017 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...
May 15, 2017
Inflection Biosciences to Present at Biotech Showcase 2017
Dublin, Ireland, January 4, 2017 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...
Jan 4, 2017
bottom of page